02186.HK
Luye Pharma Group Ltd.
HKSE · Healthcare · Drug Manufacturers - General · CN
HKD 1.59
+0.96%Margins
Gross margin
63.7%
EBITDA margin
31.3%
EBIT margin
18.5%
Net margin
11.4%
FCF margin
16.9%
4.5%
Return on equity
2.0%
Return on assets
4.0%
Return on invested capital
0.18x
Asset turnover
HKD 1.1B
Cash from operations
HKD 3.14
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026